| Name | Title | Contact Details |
|---|
Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the Company`s proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex has also developed a blood volume monitor for use in hospitals and surgery centers.
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.
SeQual is committed to a program of continual improvement and expansion of its air separation product line. We constantly strive to identify new opportunities for on-site gas separation that will benefit our customers by improving or cost-reducing their
A world-leading medical solutions company We design and supply medical solutions to enhance performance in healthcare – from the hospital to the home.
Sechrist Industries Inc is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.